NAME UND VERWENDUNGSZWECK .........................................................................................................................1
VERFAHRENSPRINZIP ................................................................................................................................................3
WARN- UND SICHERHEITSHINWEISE .......................................................................................................................6
SICHERHEITSHINWEISE ...............................................................................................................................6
VORSICHTSMASSNAHMEN ..........................................................................................................................7
ZERVIXPROBEN IN STM..............................................................................................................................11
ZERVIXBIOPSIEN .........................................................................................................................................11
TESTVERFAHREN......................................................................................................................................................12
GERÄTEANWENDUNG .........................................................................................................................12
DENATURIERUNG........................................................................................................................................13
MISCHEN UND DENATURIEREN ................................................................................................................17
Manuelles Vortexverfahren..............................................................................................................17
HYBRIDISIERUNG ........................................................................................................................................19
HYBRID CAPTURE .......................................................................................................................................21
HYBRIDNACHWEIS ......................................................................................................................................22
SPÜLEN ........................................................................................................................................................23
Manuelles Spülverfahren: ................................................................................................................24
SIGNALVERSTÄRKUNG ............................................................................................................................................24
BERECHNUNG DER GRENZWERTE ........................................................................................................................27
QUALITÄTSKONTROLLE ..........................................................................................................................................28
LEISTUNGSMERKMALE ............................................................................................................................................29
PATIENTENMANAGEMENT ..................................................................................................................29
ZUR KOLPOSKOPIE..............................................................................................................................32
ANALYTISCHE EMPFINDLICHKEIT.............................................................................................................36
KLINISCHEN POPULATION ..................................................................................................................37
REPRODUZIERBARKEIT .............................................................................................................................37
KREUZREAKTIVITÄT .................................................................................................................................................39
KREUZREAKTIVITÄTSPANEL .....................................................................................................................39
KREUZHYBRIDISIERUNG............................................................................................................................40
INHALT
i